Ranbaxy gets nod to market Ran-Simvastatin tabs in Canada

Ranbaxy Laboratories Limited (RLL) has received final approval in Canada to manufacture and market Ran-Simvastatin 5 mg, 10 mg, 20 mg, 40 mg and 80 mg tablets (simvastatin) from Health Canada, Therapeutic Products Directorate (TPD). 

Total generic market size of simvastatin tablets in Canada is $153 million ($CAD) [IMS-CDH: October 2008]. Ran-Simvastatin tablets are indicated for use as a lipid metabolism regulator.

Comments

Popular posts from this blog

Trump wants more mental health care; Alabama says it's trying

Smokefree Mumbai campaign responds to recent study by BCM, Houston that claims smoking create stronger memory